Vaccines, Blood & Biologics

2012 Biological New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) Approvals

This list reflects information regarding the applications as of the approval date.  It is not updated with regard to applicant or application status changes.

Indication for UseNDA NumberApplicantApproval Date
Anticoagulant Citrate Dextrose Solution, USP    (ACD-A)For the extracorporeal processing of blood with Autologous PRP systems in production of platelet rich plasma (PRP) for in vitro use.
BA110057Arteriocyte Medical Systems, Inc.
45 South Street, Suite 3
Hopkinton, MA 01748

Page Last Updated: 01/09/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English